Wednesday, June 10, 2026
🇺🇸 FDA

biotech · Advanced Solid Tumors · Seasonal Allergic Rhinitis · PRME

Prime Medicine

Prime Medicine clinical programs — 17 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
60 First St, Cambridge, Massachusetts 02141, US HQ
2019 Founded
185 Employees
Public company Type
PRME · NYSE Ticker
Company details
Status
Public
HQ
60 First St, Cambridge, Massachusetts 02141, US
Founded
2019
Employees
185
Programs
17
Drugs
6
Patents
127
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Prime Medicine projects

17 ClinicalTrials.gov programs sponsored by Prime Medicine.

Prime Medicine has 17 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

17 programs

Clinical programs

  1. PG-011 nasal spray 0.6%(twice daily)

    Prime Medicine

    Seasonal Allergic Rhinitis

    phase 3 small molecule active

    1 trial

  2. PG-011Gel

    Prime Medicine

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  3. Recommended treatment schedule

    Prime Medicine

    COVID-19

    phase 3 small molecule terminated

    1 trial

  4. Bemarituzumab

    Prime Medicine

    Gastric Cancer

    phase 2 mab completed

    1 trial

  5. FP-1039

    Prime Medicine

    Endometrial Cancers With FGFR2 Mutations

    phase 2 small molecule terminated

    1 trial

  6. FPA008

    Prime Medicine

    Pigmented Villonodular Synovitis

    phase 2 mab completed

    1 trial

  7. PM359

    Prime Medicine

    Chronic Granulomatous Disease

    phase 2 mab active

    1 trial

  8. Pumecitinib Nasal Spray 0.3%

    Prime Medicine

    Seasonal Allergic Rhinitis

    phase 2 small molecule active

    1 trial

  9. Bemarituzumab

    Prime Medicine

    Gastrointestinal Cancer

    phase 1 mab completed

    1 trial

  10. Cabiralizumab

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab completed

    1 trial

  11. FP-1039

    Prime Medicine

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  12. FPA008

    Prime Medicine

    Healthy

    phase 1 small molecule terminated

    1 trial

  13. FPA144

    Prime Medicine

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  14. FPA150

    Prime Medicine

    Breast Cancer

    phase 1 mab terminated

    1 trial

  15. FPT155

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab terminated

    1 trial

  16. PG-033

    Prime Medicine

    Lichen Simplex Chronicus

    phase 1 small molecule active

    1 trial

  17. Artificial intelligence in diagnosis

    Prime Medicine

    Artificial Intelligence (AI) in Diagnosis

    other active

    1 trial

Frequently asked questions

How many clinical projects does Prime Medicine have?

17 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.